These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 11061507

  • 1. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.
    Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, Schellekens AP, Bus JW, Bravenboer B, Hermus AR.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3592-6. PubMed ID: 11061507
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN, Abdelrazek S, Szumowski P, Rogowski F, Sykała M, Kostecki J, Kociura-Sawicka A, Jurgilewicz D, Myśliwiec J.
    Nucl Med Rev Cent East Eur; 2016 Oct; 19(1):3-11. PubMed ID: 26841373
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA, Hermus AR, Ross HA, Buijs WC, Edelbroek MA, Bus JW, Corstens FH, Huysmans DA.
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial.
    Nielsen VE, Bonnema SJ, Boel-Jørgensen H, Veje A, Hegedüs L.
    J Clin Endocrinol Metab; 2005 Jan; 90(1):79-83. PubMed ID: 15494456
    [Abstract] [Full Text] [Related]

  • 9. Effect of recombinant human TSH on the uptake of radioactive iodine ((123)I) by the thyroid gland in healthy beagles.
    Campos M, Peremans K, Duchateau L, Dobbeleir A, Vandermeulen E, van Hoek I, Paes G, Daminet S.
    Domest Anim Endocrinol; 2010 Nov; 39(4):215-21. PubMed ID: 20688462
    [Abstract] [Full Text] [Related]

  • 10. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects.
    Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1660-4. PubMed ID: 11297600
    [Abstract] [Full Text] [Related]

  • 11. Recombinant human thyrotropin administration enhances thyroid uptake of radioactive iodine in hyperthyroid cats.
    van Hoek I, Daminet S, Vandermeulen E, Dobbeleir A, Duchateau L, Peremans K.
    J Vet Intern Med; 2008 Apr; 22(6):1340-4. PubMed ID: 18798789
    [Abstract] [Full Text] [Related]

  • 12. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
    Silva MN, Rubió IG, Romão R, Gebrin EM, Buchpiguel C, Tomimori E, Camargo R, Cardia MS, Medeiros-Neto G.
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
    [Abstract] [Full Text] [Related]

  • 13. The effect of recombinant human tsh on the thyroid (123)i uptake in iodide treated normal subjects.
    Lawrence JE, Emerson CH, Sullaway SL, Braverman LE.
    J Clin Endocrinol Metab; 2001 Jan; 86(1):437-40. PubMed ID: 11232037
    [Abstract] [Full Text] [Related]

  • 14. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients.
    Cohen O, Ilany J, Hoffman C, Olchovsky D, Dabhi S, Karasik A, Goshen E, Rotenberg G, Zwas ST.
    Eur J Endocrinol; 2006 Feb; 154(2):243-52. PubMed ID: 16452537
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M, Cappi C, Santaniello B, Ceresola E, Augeri C, Lagasio C, Minuto F.
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [Abstract] [Full Text] [Related]

  • 16. Serum thyroxine and age--rather than thyroid volume and serum TSH--are determinants of the thyroid radioiodine uptake in patients with nodular goiter.
    Bonnema SJ, Fast S, Nielsen VE, Boel-Jørgensen H, Grupe P, Andersen PB, Hegedüs L.
    J Endocrinol Invest; 2011 Mar; 34(3):e52-7. PubMed ID: 20834199
    [Abstract] [Full Text] [Related]

  • 17. 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers.
    Pena S, Arum S, Cross M, Magnani B, Pearce EN, Oates ME, Braverman LE.
    J Clin Endocrinol Metab; 2006 Feb; 91(2):506-10. PubMed ID: 16317054
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.
    Braverman L, Kloos RT, Law B, Kipnes M, Dionne M, Magner J.
    Endocr Pract; 2008 Oct; 14(7):832-9. PubMed ID: 18996810
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
    Fast S, Hegedüs L, Grupe P, Nielsen VE, Bluhme C, Bastholt L, Bonnema SJ.
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346
    [Abstract] [Full Text] [Related]

  • 20. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M, Kyriazopoulou V, Paraskevopoulou P, Vagenakis AG, Markou KB.
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.